Founded in 2012, HALO Medical Technologies is dedicated to revolutionizing diagnostic ultrasound for pelvic floor diagnosis. The company's core mission is to provide advanced imaging solutions that enhance clinical outcomes and patient care. Their product lineup includes the Catalyst XL system, which offers high-resolution visual imaging and video recording of the anal canal, the Genie Reader Service for investigating fecal incontinence, and the MidCRYSTL probe for optimal transrectal imaging. HALO also supplies various ultrasound accessories and latex-free covers, focusing on improving diagnostic accuracy and ease of use for clinicians.

Notable figures affiliated with HALO Medical Technologies include key medical professionals and investors who have supported the company's growth and innovation. Since its inception, HALO has achieved significant milestones, such as the development of high-resolution 2D/3D imaging systems and modern software that guides clinicians through each stage of the examination process. The company's impact is evident in its ability to transform how ultrasound exams are performed and reviewed, ultimately enhancing patient care and diagnostic precision.